z-logo
open-access-imgOpen Access
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
Author(s) -
Robert Lesurf,
Miriam R. R. Aure,
Hanne Håberg Mørk,
Valeria Vitelli,
Steinar Lundgren,
AnneLise BørresenDale,
Vessela N. Kristensen,
Fredrik Wärnberg,
Michael Hallett,
Thérese Sørlie,
Torill Sauer,
Jürgen Geisler,
Solveig Hofvind,
Elin Borgen,
Olav Engebråten,
Øystein Fodstad,
Øystein Garred,
Gry Aarum Geitvik,
Rolf Kåresen,
Bjørn Naume,
Gunhild M. Mælandsmo,
Hege G. Russnes,
Ellen Schlichting,
Ole Christian Lingjærde,
Kristine Kleivi Sahlberg,
Helle Kristine Skjerven,
Britt Fritzman
Publication year - 2016
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2016.06.051
Subject(s) - breast cancer , biology , tumor progression , ductal carcinoma , cancer , disease , cancer research , carcinoma in situ , in situ , pathology , oncology , medicine , genetics , physics , meteorology
Breast cancer consists of at least five main molecular "intrinsic" subtypes that are reflected in both pre-invasive and invasive disease. Although previous studies have suggested that many of the molecular features of invasive breast cancer are established early, it is unclear what mechanisms drive progression and whether the mechanisms of progression are dependent or independent of subtype. We have generated mRNA, miRNA, and DNA copy-number profiles from a total of 59 in situ lesions and 85 invasive tumors in order to comprehensively identify those genes, signaling pathways, processes, and cell types that are involved in breast cancer progression. Our work provides evidence that there are molecular features associated with disease progression that are unique to the intrinsic subtypes. We additionally establish subtype-specific signatures that are able to identify a small proportion of pre-invasive tumors with expression profiles that resemble invasive carcinoma, indicating a higher likelihood of future disease progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom